Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 


 
 Table of Contents  
CASE REPORT
Year : 2013  |  Volume : 1  |  Issue : 1  |  Page : 53-54

Protagonist role of oral atropine in the subacute phase of organophosphate poisoning


1 Department of Paediatrics, Columbia Asia Hospital, Ghaziabad, India
2 Paediatrician, Columbia Asia Hospital, Ghaziabad, India
3 Department of Paediatrics, RLJ Hospital, Sri Devraj Urs Medical College, Kolar, Karnataka, India
4 Department of Biochemistry, Scientific Research Laboratory-AHS, Sri Devaraj Urs Academy of Higher Education and Research, Kolar, Karnataka, India

Date of Web Publication30-Dec-2013

Correspondence Address:
Pradeep Kumar Vegi
Research Scientist, Proteomics, Central Research Laboratory, Cell Biology and Molecular Genetics, Sri Devaraj Urs Academy of Higher Education and Research, Kolar, Karnataka - 563 101
India
Login to access the Email id

Source of Support: Columbia Asia Hospital and Sri Devaraj Urs Academy of Higher Education and Research, Conflict of Interest: None


DOI: 10.4103/2348-0149.123966

Rights and Permissions
  Abstract 

Organophosphates (OPs) are widely used as insecticides. Accidental OP poisoning is reported world over. These compounds inhibit the enzyme acetylcholinesterase within the peripheral and central nervous system by phosphorylation of its esteratic site. The resultant accumulation of acetylcholine at the cholinergic receptor sites, leads to signs of cholinergic toxicity. Accidental OP ingestion has rarely been reported in young toddlers. We report a case of acute OP poisoning (dichlorvos) in an 18-month-old boy with special reference to use of oral atropine treatment in subacute phase.

Keywords: Oral atropine, organophosphate poising, subacute phase, subcutaneous


How to cite this article:
Sharma S, Chauhan R, Venkateshwara Prasad K N, Dayanand C D, Vegi PK. Protagonist role of oral atropine in the subacute phase of organophosphate poisoning. Niger J Exp Clin Biosci 2013;1:53-4

How to cite this URL:
Sharma S, Chauhan R, Venkateshwara Prasad K N, Dayanand C D, Vegi PK. Protagonist role of oral atropine in the subacute phase of organophosphate poisoning. Niger J Exp Clin Biosci [serial online] 2013 [cited 2022 Dec 10];1:53-4. Available from: https://www.njecbonline.org/text.asp?2013/1/1/53/123966


  Introduction Top


The standard management of organophosphate (OP) poisoning in children includes intravenous (IV) atropine sulfate and IV pralidoxime chloride along with supportive measures. [1] The role of subcutaneous route subsequently followed by oral atropine in subacute phase of OP poisoning is discussed after successful case management with home-based oral atropine and daily outpatient follow-up.


  Case Report Top


An 18-month-old boy brought to emergency department by his parents with accidental ingestion of insecticide solution (DDVP-dichlorvas). On arrival his heart rate was 136/min, blood pressure of 102/45 mmHg, and SpO 2 was 82% in room air. His respiratory rate was 34/min and the child was only responsive to painful stimuli. Both pupils were pin point; the tone was normal and no focal neurological sign. The child had excessive oral secretion, rhinorrhea, and mild bronchospasm. Foul smelling soft stool was present in diaper; rest of the examination was unremarkable.

The child was managed with oxygen inhalation, IV atropine every 15 min, single dose of PAM IV, and other supportive measures. The child was kept in Pediatric Intensive Care Unit (PICU) for 1 day. Following clinical improvement, atropine was given every 2 h and followed 3-4 hourly. The child stayed in our hospital for a total of 58 h. Unfortunately due to the financial constraints this patient was discharged on persistent request. At time of discharge the child continued to have mild muscarinic features of organophosphorus poisoning which mandated continuation of atropine. On discharge, the child father agreed to give prescribed medicine and bring the child for outpatient department daily.

The child was prescribed 0.4 mg inj. atropine subcutaneous every 4 h for 1 day, after which the same dose (injectable atropine) was given orally every 4 h for 2 days, and then tapered to 0.3 mg 6 hourly and then 0.2 mg every 8 h. All of these doses were greater than 0.025-0.05 mg/kg the atropine challenge dose which indicates that this child was having on going cholinesterase toxicity. After stopping atropine the child was also followed daily for 72 h during which the symptoms of cholinergic excess did not occur/recur. Also during treatment at home, there was no adverse effect of atropine excess noted.


  Discussion Top


Standard therapy of OP poisoning is the IV administration of atropine and pralidoxime. [1] Atropine, a competitive inhibitor of acetylcholine at muscarinic receptors, can prevent parasympathetic stimulation. Pralidoxime is used to reactivate cholinesterase enzymes. [2] The route recommended for atropine administration in OP poisoning in order of preference is IV, intraosseous, inhalation, intramuscular, and oral. IV therapy should always be used to treat acute poisoning if possible. [1] Subcutaneous atropine has been recommended as premedication 30-60 min before induction. [3] Atropine sulfate is not licensed for use by oral route and there is no preparation available for oral use in India. British National Formulary for children mentions that for administration by mouth, injection solution may be given orally (that is how it was used in our case). [4] When used orally, atropine is well absorbed from the gastrointestinal (GI) tract. The site of absorption appears to be upper small intestine and nearly 90% of the dose is absorbed when given orally. [5] Peak plasma concentration is reached within 1 h and the duration of action appears to be 2-6 h. The half-life of atropine is 2-3 h, being longer in infants <2 years of age. Atropine is well-distributed throughout the body and it crosses blood brain barrier and placental barrier easily. Atropine is metabolized in liver and is excreted in urine of which at least 50% is unchanged. [5]

In a recent study of oral treatment of OP poisoning in mice, Bowls et al., were able to show that both oral atropine and a combination of oral atropine and pralidoxime improved survival, and combination therapy achieved statistical significance. [6] In humans, oral atropine use in organophosphorus poisoning has been described after critical phase is over and in patients requiring prolonged atropinization to prevent relapse, therapy also appears to be more commonly prolonged with highly lipophilic OPs. [7],[8],[9],[10],[11] Oral administration of atropine has been reported as being useful for stable patients on IV therapy for several days or weeks, which need slow weaning. [12] If massive poisonings occur from terrorist attacks, chemical warfare, or a large spill; it may be difficult to treat large numbers of people with IV medications due to limited resources and personnel. Oral medications might be considered to treat those with mild poisoning. Advantages of oral medications include ease of administration, lower cost, less stringent criteria for sterility, and longer shelf-life. [6]

In resource poor settings, further complicated by financial constraints of the patients, hospital-based management of organophosphorus poisoning cases becomes difficult, hence alternative routes of atropine administration has to be explored. To the best of our knowledge, this is the first reported case from India of successful management of organophosphorous poisoning in a child where injectable atropine preparation was used subcutaneously and then orally with outpatient based monitoring.


  Acknowledgement Top


We acknowledge Columbia Asia Hospital and Sri Devaraj Urs Academy of Higher Education and Research for their cooperation and the family members of this particular case.

 
  References Top

1.Kumar SV, Fareedullah M, Sudhakar Y, Venkateshwarlu B. Current review on organophosphorus poisoning. Arch Appl Sci Res 2010;2:199-215.  Back to cited text no. 1
    
2.Cholinesterase Inhibitors. Available from: www.atsdr.cdc.gov/csem/csem.html [Last accessed date on 2012].  Back to cited text no. 2
    
3.Joshi S, Biswas B, Mallaet G. Update in Anesthesia 2005;19:13.  Back to cited text no. 3
    
4.BNF for Children 2007 - The Essential Resource for Clinical Use of Medicines in Children Nursing Standard, 2008, 22:31. http://dx.doi.org/10.7748/ns2008.01.22.19.31.b710   Back to cited text no. 4
    
5.Available from: www.inchem.org/documents/antidote/antidote/atropine.htm [Last accessed date on 2012 Aug 30].  Back to cited text no. 5
    
6.Bowls BJ, Freeman JM Jr, Luna JA, Meggs WJ. Oral treatment of organophosphate poisoning in mice. Acad Emerg Med 2003;10:286-8.  Back to cited text no. 6
    
7.Borowitz SM. Prolonged organophosphate toxicity in a twenty-six-month-old child. J Pediatr 1988;112:302-4.  Back to cited text no. 7
    
8.du Toit PW, Muller FO, van Tonder WM, Ungerer MJ. Experience with the intensive care management of organophosphate insecticide poisoning. S Afr Med J 1981;60:227-9.  Back to cited text no. 8
    
9.Hayes MM, van der Westhuizen NG, Gelfand M. Organophosphate poisoning in Rhodesia. A study of the clinical features and management of 105 patients. S Afr Med J 1978;54:230-4.  Back to cited text no. 9
    
10.LeBlanc FN, Benson BE, Gilg AD. A severe organophosphate poisoning requiring the use of an atropine drip. J Toxicol Clin Toxicol 1986;24:69-76.  Back to cited text no. 10
    
11.Yoshida M, Shimada E, Yamanaka S, Aoyama H, Yamamura Y, Owada S. A case of acute poisoning with fenitrothion (Sumithion). Hum Toxicol 1987;6:403-6.  Back to cited text no. 11
    
12.Worrell CL. The management of organophosphate intoxication. South Med J 1975;68:335-9.  Back to cited text no. 12
    




 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
   Abstract
  Introduction
  Case Report
  Discussion
  Acknowledgement
   References

 Article Access Statistics
    Viewed3785    
    Printed260    
    Emailed0    
    PDF Downloaded250    
    Comments [Add]    

Recommend this journal